Status:
COMPLETED
Epidemiological Study on Haemophilia Care and Orthopaedic Status in Developing Countries
Lead Sponsor:
Novo Nordisk A/S
Conditions:
Congenital Bleeding Disorder
Haemophilia A
Eligibility:
MALE
6-18 years
Brief Summary
This study is conducted in Africa and Asia. The aim of this study is to evaluate in the participating countries the orthopaedic status and the degree of arthropathy of severe haemophilia patients in g...
Eligibility Criteria
Inclusion
- Patient (and/or parents or the patient's legally acceptable representative, if applicable) must give signed and dated informed consent before enrolment in the study
- Male patients at least 6 years old with diagnosis of severe congenital haemophilia A or B with or without inhibitors
- Patients receiving on demand replacement factors/bypassing agents therapy
Exclusion
- Clinically relevant coagulation disorders other than congenital haemophilia A or B
- Patients on currently active treatment for HCV (Hepatitis C Virus) or HIV (Human Immune Deficiency Virus) infections
Key Trial Info
Start Date :
January 1 2012
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 1 2012
Estimated Enrollment :
282 Patients enrolled
Trial Details
Trial ID
NCT01503567
Start Date
January 1 2012
End Date
September 1 2012
Last Update
January 18 2017
Active Locations (4)
Enter a location and click search to find clinical trials sorted by distance.
1
Novo Nordisk Investigational Site
Bangalore, India, 560001
2
Novo Nordisk Investigational Site
Casablanca, Morocco, 20000
3
Novo Nordisk Investigational Site
Muscat, Oman
4
Novo Nordisk Investigational Site
Sandton, South Africa, 2146